Cogent Biosciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $4,292 | $0 |
Gross Profit | -1,157 | -1,138 | 2,146 | -1,097 |
EBITDA | -72,058 | -73,795 | -66,769 | -74,317 |
EBIT | -73,215 | -74,933 | -67,927 | -75,414 |
Net Income | -73,529 | -71,986 | -67,927 | -70,634 |
Net Change In Cash | 0 | 0 | 4,292 | 0 |
Free Cash Flow | -54,673 | -67,058 | -60,652 | -52,264 |
Cash | 127,598 | 126,003 | 98,165 | 97,045 |
Basic Shares | 114,466 | 113,307 | 110,461 | 110,165 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -4,401 | -3,588 | -5,878 | -147 |
EBITDA | -275,939 | -205,860 | -141,961 | -75,404 |
EBIT | -278,389 | -208,130 | -147,839 | -75,551 |
Net Income | -255,859 | -192,410 | -132,643 | -71,806 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -79,798 | -22,506 | ||
Free Cash Flow | -208,364 | -156,420 | -125,501 | -60,482 |
Cash | 98,165 | 53,229 | 139,886 | 219,684 |
Basic Shares | 103,856 | 79,657 | 58,739 | 38,730 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.58 |
2025-03-31 | -$0.52 |
2024-12-31 | -$0.09 |
